Transplantation

Overview

Journal JAMA

Publisher American Medical Association

Specialty General Medicine

Date 1990 May 16

PMID 2329677

Citations 14

Authors

T E Starzl

J J Fung

Affiliations

Soon will be listed here.

Citing Articles

Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet.

Starzl T, Todo S, Demetris A, Fung J Am J Kidney Dis. 1998; 31(6 Suppl 1):S7-14.

PMID: 9631858 PMC: 2989854. DOI: 10.1053/ajkd.1998.v31.pm9631858.

The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation.

Fung J, Eliasziw M, Todo S, Jain A, Demetris A, McMichael J J Am Coll Surg. 1996; 183(2):117-25.

PMID: 8696542 PMC: 2677969.

Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506.

Takaya S, Bronsther O, Abu-Elmagd K, Ramos H, Fung J, Todo S Transplant Proc. 1993; 25(3):2381-5.

PMID: 7685953 PMC: 2994248.

Adverse effects of FK 506 overdosage after liver transplantation.

Alessiani M, Cillo U, Fung J, Irish W, Abu-Elmagd K, Jain A Transplant Proc. 1993; 25(1 Pt 1):628-34.

PMID: 7679825 PMC: 2996874.

Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Peters D, Fitton A, Plosker G, Faulds D Drugs. 1993; 46(4):746-94.

PMID: 7506654 DOI: 10.2165/00003495-199346040-00009.

References

Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T . FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo). 1987; 40(9):1256-65. DOI: 10.7164/antibiotics.40.1256. View

Siekierka J, Hung S, Poe M, Lin C, Sigal N . A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature. 1989; 341(6244):755-7. DOI: 10.1038/341755a0. View

. Second International Workshop on FK 506. A potential breakthrough in immunosuppression: clinical implications. October 31, 1989, Barcelona, Spain. Proceedings. Transplant Proc. 1990; 22(1):5-113. View

Fischer G, Bang H . The refolding of urea-denatured ribonuclease A is catalyzed by peptidyl-prolyl cis-trans isomerase. Biochim Biophys Acta. 1985; 828(1):39-42. DOI: 10.1016/0167-4838(85)90006-8. View

Francavilla A, Barone M, Todo S, Zeng Q, Porter K, Starzl T . Augmentation of rat liver regeneration by FK 506 compared with cyclosporin. Lancet. 1989; 2(8674):1248-9. PMC: 2952524. DOI: 10.1016/s0140-6736(89)91853-9. View

Todo S, Fung J, Demetris A, Jain A, Venkataramanan R, Starzl T . Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc. 1990; 22(1):13-6. PMC: 2903882. View

Cantarovich D, Le Mauff B, Hourmant M, Giral M, Denis M, Hirn M . Anti-interleukin 2 receptor monoclonal antibody in the treatment of ongoing acute rejection episodes of human kidney graft--a pilot study. Transplantation. 1989; 47(3):454-7. DOI: 10.1097/00007890-198903000-00011. View

Shieh B, Stamnes M, Seavello S, Harris G, Zuker C . The ninaA gene required for visual transduction in Drosophila encodes a homologue of cyclosporin A-binding protein. Nature. 1989; 338(6210):67-70. DOI: 10.1038/338067a0. View

Harding M, Handschumacher R, Speicher D . Isolation and amino acid sequence of cyclophilin. J Biol Chem. 1986; 261(18):8547-55. View

10.

Takahashi N, Hayano T, Suzuki M . Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature. 1989; 337(6206):473-5. DOI: 10.1038/337473a0. View

11.

Harding M, Galat A, Uehling D, Schreiber S . A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature. 1989; 341(6244):758-60. DOI: 10.1038/341758a0. View

12.

Kahan B . Cyclosporine. N Engl J Med. 1989; 321(25):1725-38. DOI: 10.1056/NEJM198912213212507. View

13.

Starzl T, Todo S, Fung J, Demetris A, Venkataramman R, Jain A . FK 506 for liver, kidney, and pancreas transplantation. Lancet. 1989; 2(8670):1000-4. PMC: 2966318. DOI: 10.1016/s0140-6736(89)91014-3. View

14.

Kirkman R, Shapiro M, Carpenter C, Milford E, Ramos E, Tilney N . Early experience with anti-Tac in clinical renal transplantation. Transplant Proc. 1989; 21(1 Pt 2):1766-8. View

15.

Fischer G, Wittmann-Liebold B, Lang K, Kiefhaber T, Schmid F . Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature. 1989; 337(6206):476-8. DOI: 10.1038/337476a0. View

16.

Kernan N, BYERS V, Scannon P, Mischak R, Brochstein J, Flomenberg N . Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin. JAMA. 1988; 259(21):3154-7. View

17.

Southard J, van Gulik T, Ametani M, Vreugdenhil P, Lindell S, Pienaar B . Important components of the UW solution. Transplantation. 1990; 49(2):251-7. DOI: 10.1097/00007890-199002000-00004. View